A detailed history of Pfg Investments, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 1,692 shares of BIIB stock, worth $271,785. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,692
Previous 1,749 3.26%
Holding current value
$271,785
Previous $405 Million 19.11%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$189.07 - $236.8 $10,776 - $13,497
-57 Reduced 3.26%
1,692 $328 Million
Q2 2024

Aug 06, 2024

SELL
$190.52 - $236.72 $20,004 - $24,855
-105 Reduced 5.66%
1,749 $405 Million
Q1 2024

Apr 22, 2024

BUY
$212.02 - $267.71 $393,085 - $496,334
1,854 New
1,854 $400 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.